Nagler's Reaction

What It Is

Principle

Medium Used

Procedure

1. The egg yolk agar plate is divided into two halves.
2. One half is smeared with specific anti-alpha toxin (antitoxin/antiserum against C. perfringens alpha-toxin).
3. The test organism is inoculated across both halves.
4. Incubated anaerobically at 37°C for 24-48 hours.

Result Interpretation

• Positive Nagler reaction: Pearly white/opaque zone of precipitation around colonies on the untreated half, with inhibition on the antitoxin-treated half - confirms C. perfringens.
• If both halves show opacity (no inhibition), the organism produces a non-specific lecithinase and is NOT C. perfringens.

Significance of Alpha-Toxin

• Damages cell membranes (lecithinase activity)
• Causes hemolysis (responsible for the double zone of hemolysis on blood agar)
• Key pathogenic factor in gas gangrene (clostridial myonecrosis)
• Also contributes to food poisoning
• Identified in clinical settings using the Nagler reaction

Key Points to Remember

• Organism identified: Clostridium perfringens (also called Cl. welchii)
• Toxin detected: Alpha-toxin (phospholipase C / lecithinase)
• Medium: Egg yolk agar
• Hallmark: Inhibition of the opaque halo by specific antitoxin on one half of the plate
• C. perfringens also shows "boxcar" (short, fat) Gram-positive rods and double zone of hemolysis on blood agar
• The antitoxin-based inhibition makes the test specific - it rules out other lecithinase-producing organisms (e.g., Bacillus cereus, C. bifermentans)

Laboratory Diagnosis of Drug-Resistant Tuberculosis (DR-TB)

Classification of Drug Resistance (WHO Definitions)

Two Major Approaches to DST

1. Phenotypic (Culture-Based) Methods

2. Genotypic (Molecular) Methods

A. PHENOTYPIC METHODS

1. Proportion Method (Reference Standard)

• Cultures inoculated on drug-free media and drug-containing media in parallel.
• Resistance defined as: >1% of colonies grow on drug-containing medium compared to drug-free control.
• Can be done on solid (Lowenstein-Jensen agar) or liquid (broth) media.
• Results on liquid media: ~7-14 days; solid media: up to 21 days or longer.
• (Murray & Nadel's Respiratory Medicine; Harrison's 22e)

2. Automated Broth-Based Systems (MGIT, BACTEC)

• Gold standard liquid culture using fluorometric/radiometric growth detection.
• First-line drugs (INH, RIF, PZA, EMB) tested using a critical concentration.
• Sensititre MycoTB plate can determine MICs for multiple drug concentrations.
• WHO recommends automated liquid culture for all Group A drugs (moxifloxacin, levofloxacin, bedaquiline, linezolid), Group B (clofazimine), and Group C (amikacin, delamanid, pyrazinamide).
• (Tietz Textbook of Laboratory Medicine 7e; Murray & Nadel)

3. Colorimetric Redox Methods

• AlamarBlue / Resazurin assay: Viable bacteria reduce the indicator, causing a color change (blue to pink = resistant). Sensitivity 98% / Specificity 99% for RIF; 97% / 98% for INH.
• Nitrate Reductase Assay (NRA): Based on M. tuberculosis reducing nitrate to nitrite. Sensitivity 97%, specificity 100% for RIF resistance.
• (Murray & Nadel's Respiratory Medicine)

4. MODS (Microscopic Observation Drug Susceptibility) Assay

• A liquid broth culture method in a multi-well plate WITH and WITHOUT antibiotics.
• Microscopy used to identify characteristic cording of M. tuberculosis complex.
• Detects resistance to RIF and INH simultaneously.
• Inexpensive, suitable for resource-limited settings.
• (Jawetz Melnick & Adelberg's Medical Microbiology 28e; Murray & Nadel)

B. GENOTYPIC (MOLECULAR) METHODS

1. GeneXpert MTB/RIF & MTB/RIF Ultra (CB-NAAT)

• The most widely deployed rapid test worldwide.
• Detects M. tuberculosis DNA AND rifampicin resistance (mutations in rpoB gene) simultaneously in unprocessed sputum in ~90 minutes.
• Uses molecular beacons (fluorescent probes) in a real-time PCR format.
• Sensitivity ~83%, Specificity ~98% for TB detection; excellent for RIF resistance.
• Xpert Ultra has higher sensitivity for paucibacillary disease (smear-negative TB, children, PLHIV).
• Rifampicin resistance on Xpert is used as a proxy marker for MDR-TB.
• (Park's PSM; Campbell's Operative Orthopaedics 15e; Comprehensive Clinical Nephrology 7e)

2. Line Probe Assays (LPA) - MTBDRplus, MTBDRsl

• Detects resistance to Rifampicin (rpoB gene) and Isoniazid (katG and inhA genes).
• Applied directly to smear-positive sputum or culture isolates.
• For smear-negative specimens: culture first, then LPA on isolate.
• PCR amplification followed by reverse hybridization onto nitrocellulose strips.
• Results in 24-48 hours from isolate.

• Detects fluoroquinolone resistance (gyrA, gyrB genes) and second-line injectable resistance (rrs, eis genes).
• WHO recommends as the initial test for rapid detection of FQ and injectable resistance in confirmed MDR-TB isolates.
• (Park's PSM; Harrison's Principles 22e)

3. Targeted Next-Generation Sequencing (tNGS)

• Amplification and sequencing of key drug resistance gene regions directly from sputum.
• Now WHO-recommended after TB diagnosis to guide comprehensive DST and treatment decisions.
• Faster than phenotypic DST; especially useful when comprehensive resistance profiling is needed.
• Commercial assays: Deeplex Myc-TB (GenoScreen) - targets 18 resistance-associated gene loci for 13 anti-TB drugs; DeepChek-TB (ABL).
• Results within 48 hours from clinical specimens.
• Still requires phenotypic confirmation for some newer drugs (bedaquiline, linezolid, pretomanid).
• (Murray & Nadel; Harrison's 22e)

4. Whole Genome Sequencing (WGS)

• The most comprehensive method - sequences the entire M. tuberculosis genome.
• Provides a complete drug resistance profile, strain typing for epidemiology, and transmission cluster analysis.
• England implemented nationwide WGS of all M. tuberculosis clinical isolates in 2017 as a public health initiative.
• Currently requires culture before processing (limitation); direct-from-sputum approaches under development.
• Best suited for reference laboratory settings.
• (Tietz Textbook of Laboratory Medicine 7e)

5. Sanger Sequencing / Pyrosequencing

• Used by reference laboratories (e.g., CDC) to predict resistance to first- and second-line drugs.
• High sensitivity and specificity compared to phenotypic DST.
• (Henry's Clinical Diagnosis 23e)

Summary: Comparison of Methods

Important Limitations of Molecular Methods

• Failure to detect a mutation does not exclude resistance - not all resistance mechanisms are known.
• Phenotypic DST remains essential to detect resistance caused by novel or unknown mutations.
• Molecular methods are adjuncts to, not replacements for, phenotypic DST.
• Testing for PZA resistance has a high false-positive rate without proper quality assurance.
• (Henry's Clinical Diagnosis; Murray & Nadel; Harrison's 22e)

WHO Recommended Diagnostic Cascade (Current Standard)

1. Universal DST for all TB patients - at minimum, test for RIF resistance.
2. Rapid molecular test (Xpert MTB/RIF) as initial test for all presumptive TB patients.
3. If RIF resistance detected - confirm MDR-TB; test 2nd-line LPA or tNGS for FQ and injectable resistance.
4. Culture-based DST for all second-line drugs in confirmed MDR-TB.
5. tNGS or WGS at reference laboratories for comprehensive resistance profiling and epidemiology.